Testing effectiveness (Phase 2)Study completedNCT00876863
What this trial is testing
Randomized, Controlled Study Evaluating CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease
Who this might be right for
Alzheimer's Disease
Sangamo Therapeutics 49